Triple Negative Breast Cancer - Leronlimab Plus Chemo Appears to Prolong Survival
Triple Negative Breast Cancer – Leronlimab Plus Chemo Appears to Prolong Survival
Straight to the Point in Triple Negative Breast Cancer Leronlimab (PRO 140) has demonstrated promising preliminary results in a phase 1b/2 clinical trial (NCT03838367) for patients with metastatic triple negative…